TYRA
Tyra Biosciences Inc
NASDAQ: TYRA · HEALTHCARE · BIOTECHNOLOGY
$34.75
+2.86% today
Updated 2026-04-30
Market cap
$2.01B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.01
Dividend yield
—
52W range
$9 – $41
Volume
1.2M
Tyra Biosciences Inc (TYRA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-39.80%
ROA
-25.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-4.06M | — | — | — |
| 2020 | $0.00 | $-9.31M | — | — | — |
| 2021 | $0.00 | $-26.14M | — | — | — |
| 2022 | $0.00 | $-51.72M | — | — | — |
| 2023 | $0.00 | $-69.13M | — | — | — |
| 2024 | $0.00 | $-86.48M | — | — | — |
| 2025 | $0.00 | $-119.95M | — | — | — |